Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

A kind of solid dispersion of alisartan medoxomil and the pharmaceutical composition containing the solid dispersion

一种阿利沙坦酯、固体分散体的技术，应用在药物制剂领域，能够解决老化、溶出性能下降等问题

Active Publication Date: 2019-06-11
SHENZHEN SALUBRIS PHARMA CO LTD
View PDF7 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, affected by factors such as prescriptions or storage conditions, the active ingredients in the solid dispersion will inevitably undergo rapid or slow aggregation and crystallization during storage, that is, the "aging phenomenon" of the solid dispersion, manifested as Preparation of preparations with qualified initial dissolution performance, the dissolution performance will decrease significantly after storage for a period of time, and the aging phenomenon will be particularly obvious when the amount of solid dispersion carrier is reduced

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of solid dispersion of alisartan medoxomil and the pharmaceutical composition containing the solid dispersion
  • A kind of solid dispersion of alisartan medoxomil and the pharmaceutical composition containing the solid dispersion
  • A kind of solid dispersion of alisartan medoxomil and the pharmaceutical composition containing the solid dispersion

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0055] prescription:

[0056]

[0057] preparation:

[0058] 1. Preparation of solid dispersion

[0059] Dissolve the drug and povidone K 29 / 32 in an appropriate amount of dichloromethane-ethanol mixed solution, then add the aqueous solution of sodium lauryl sulfate and egg yolk lecithin, mix well, and set aside. Add crospovidone (I) into the fluidized bed, spray the prepared solution into the fluidized bed with a spray gun to granulate in the top spray mode, and dry to obtain the solid dispersion of alisartan medoxomil; further XRD experiment detection found that Alisartan The active ingredient of tannyl ester is highly dispersed in the solid dispersion, which proves that the preparation effect of the solid dispersion is as expected.

[0060] 2. Preparation of pharmaceutical composition

[0061] The solid dispersion is uniformly mixed with additional auxiliary materials, compressed into tablets to obtain plain tablets, and film-coated to obtain the alisartan medoxomil p...

Embodiment 2

[0063] prescription:

[0064]

[0065] preparation:

[0066] 1. Preparation of solid dispersion

[0067] Dissolve the drug and povidone K29 / 32 in an appropriate amount of dichloromethane-ethanol mixed solution, then add an aqueous solution of sodium lauryl sulfate, mix well, and set aside. Add crospovidone (I) into the fluidized bed, spray the prepared solution into the fluidized bed with a spray gun to granulate in the top spray mode, and dry to obtain the solid dispersion of alisartan medoxomil; further XRD experiment detection found that Alisartan The active ingredient of tannyl ester is highly dispersed in the solid dispersion, which proves that the preparation effect of the solid dispersion is as expected.

[0068] 2. Preparation of pharmaceutical composition

[0069] The solid dispersion is uniformly mixed with additional auxiliary materials, compressed into tablets to obtain plain tablets, and film-coated to obtain the alisartan medoxomil pharmaceutical compositio...

Embodiment 3

[0071] prescription:

[0072]

[0073] preparation:

[0074] 1. Preparation of solid dispersion

[0075] Dissolve the drug and povidone K29 / 32 in an appropriate amount of dichloromethane-ethanol mixed solution, then add egg yolk lecithin, dissolve and mix evenly, and set aside. Microcrystalline cellulose and crospovidone (I) are added in the fluidized bed, and the prepared solution is sprayed into the fluidized bed with a spray gun to granulate in the top spray mode, and dried to obtain alisartan medoxomil solid dispersion; further XRD Experimental testing found that the active ingredient of alisartan medoxomil was highly dispersed in the solid dispersion, which proved that the preparation effect of the solid dispersion reached expectations.

[0076] 2. Preparation of pharmaceutical composition

[0077] The solid dispersion is uniformly mixed with additional auxiliary materials, compressed into tablets to obtain plain tablets, and film-coated to obtain the alisartan medo...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a high-load solid dispersion of alisartan medoxomil. On the premise of ensuring the stability and dissolution rate of the preparation, by adding a surfactant, the content of the active ingredient in the solid dispersion is effectively increased. The solid dispersion The drug loading capacity of the body is higher than that of the prior art. The pharmaceutical composition containing the solid dispersion has the characteristics of good dissolution performance, good stability, etc., meets the requirements of clinical medication, and improves medication compliance of patients.

Description

technical field [0001] The invention belongs to the field of pharmaceutical preparations, in particular, the invention relates to a solid dispersion of alisartan medoxomil and a pharmaceutical composition containing the solid dispersion. Background technique [0002] Alisartan medoxomil (CAS: 947331-05-7), chemical name: 2-butyl-4-chloro-1-[2'-(1H-tetrazol-5-yl)-1,1'-biphenyl -Methyl]-imidazole-5-carboxylic acid, 1-[(isopropoxy)-carbonyloxy]-methyl ester, trade name: Xinlitan, is a new type of angiotensin Ⅱ receptor antagonist . Chinese patent CN200680000397.8 discloses the structural formula of the allisartan medoxomil compound. The allisartan medoxomil is less toxic and has a better antihypertensive effect than similar products (such as losartan). Its antihypertensive effect. Alisartan medoxomil is an ester derivative of EXP3174, its solubility in water is small, and the preparations obtained by conventional preparation methods are difficult to meet the needs of clinica...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K9/36A61K31/4178A61K47/20A61K47/24A61K47/26A61K47/22A61K47/44A61K47/32A61K47/38A61P9/12
CPCA61K47/32A61K47/34A61K47/38A61K9/14A61K31/4178A61P43/00A61P9/12A61K9/146A61K9/2009A61K9/2013A61K9/2018A61K9/2027A61K9/2031A61K9/2054A61K9/2059A61K9/28
Inventor 叶冠豪卜水
Owner SHENZHEN SALUBRIS PHARMA CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com